Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 3
Submit an article Journal homepage
998
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine

Xiaolan Yonga Phase I Clinical Trial Center, Chengdu Xinhua Hospital Affiliated to North Sichuan Medical College, Chengdu, Sichuan, ChinaView further author information
,
Jun Liub Pulmonary and Critical Care Medicine, Chongqing Red Cross Hospital (People’s Hospital of Jiangbei District), Chongqing, ChinaView further author information
,
Ying Zengc Department of Medicine and Registration, Guangzhou Patronus Biotech Co. Ltd, Guangzhou, Guangdong, China;d Department of Medicine and Registration, Yantai Patronus Biotech Co. Ltd, Yantai, Shandong, ChinaView further author information
,
Jing Nieb Pulmonary and Critical Care Medicine, Chongqing Red Cross Hospital (People’s Hospital of Jiangbei District), Chongqing, ChinaView further author information
,
Xuelian Cuie Department of Medicine, Chongqing Medleader Bio-Pharm Co. Ltd, Chongqing, ChinaView further author information
,
Tao Wange Department of Medicine, Chongqing Medleader Bio-Pharm Co. Ltd, Chongqing, ChinaView further author information
,
Yilin Wange Department of Medicine, Chongqing Medleader Bio-Pharm Co. Ltd, Chongqing, ChinaView further author information
,
Yiyong Chene Department of Medicine, Chongqing Medleader Bio-Pharm Co. Ltd, Chongqing, ChinaView further author information
,
Wei Kangc Department of Medicine and Registration, Guangzhou Patronus Biotech Co. Ltd, Guangzhou, Guangdong, China;d Department of Medicine and Registration, Yantai Patronus Biotech Co. Ltd, Yantai, Shandong, ChinaView further author information
,
Zhonghua Yangc Department of Medicine and Registration, Guangzhou Patronus Biotech Co. Ltd, Guangzhou, Guangdong, China;d Department of Medicine and Registration, Yantai Patronus Biotech Co. Ltd, Yantai, Shandong, ChinaView further author information
&
Yan Liue Department of Medicine, Chongqing Medleader Bio-Pharm Co. Ltd, Chongqing, China;f College of Pharmacy, Chongqing Medical University, Chongqing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2267869 | Received 23 Jul 2023, Accepted 04 Oct 2023, Published online: 19 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.